Srikripa Devarakonda
Stock Analyst at Truist Securities
(4.45)
# 324
Out of 5,124 analysts
80
Total ratings
59.46%
Success rate
18.23%
Average return
Main Sectors:
Stocks Rated by Srikripa Devarakonda
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SEPN Septerna | Initiates: Buy | $34 | $27.90 | +21.86% | 1 | Dec 15, 2025 | |
| KYMR Kymera Therapeutics | Maintains: Buy | $80 → $116 | $77.81 | +49.08% | 6 | Dec 9, 2025 | |
| TERN Terns Pharmaceuticals | Maintains: Buy | $35 → $56 | $40.40 | +38.61% | 4 | Dec 9, 2025 | |
| MDGL Madrigal Pharmaceuticals | Maintains: Buy | $580 → $640 | $582.34 | +9.90% | 2 | Nov 19, 2025 | |
| INCY Incyte | Reiterates: Hold | $79 → $93 | $98.77 | -5.84% | 12 | Oct 29, 2025 | |
| PTGX Protagonist Therapeutics | Maintains: Buy | $76 → $88 | $87.34 | +0.76% | 3 | Oct 28, 2025 | |
| SRRK Scholar Rock Holding | Maintains: Buy | $54 → $44 | $44.05 | -0.11% | 5 | Oct 20, 2025 | |
| VTRS Viatris | Initiates: Buy | $15 | $12.45 | +20.48% | 1 | Oct 15, 2025 | |
| MBX MBX Biosciences | Initiates: Buy | $50 | $31.54 | +58.53% | 1 | Oct 15, 2025 | |
| REGN Regeneron Pharmaceuticals | Maintains: Buy | $940 → $812 | $771.87 | +5.20% | 8 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $21 → $11 | $11.86 | -7.25% | 1 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $210 → $199 | $175.99 | +13.07% | 4 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $25 | $20.36 | +22.79% | 5 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,029 → $1,038 | $1,074.68 | -3.41% | 4 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $211 → $217 | $228.49 | -5.03% | 3 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $32 | $24.90 | +28.51% | 1 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $50 | $24.82 | +101.49% | 6 | Nov 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $54 | $1.24 | +4,254.84% | 1 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $15 | $7.72 | +94.30% | 7 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $18.97 | +89.77% | 1 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $86 → $70 | $63.54 | +10.17% | 4 | May 29, 2024 |
Septerna
Dec 15, 2025
Initiates: Buy
Price Target: $34
Current: $27.90
Upside: +21.86%
Kymera Therapeutics
Dec 9, 2025
Maintains: Buy
Price Target: $80 → $116
Current: $77.81
Upside: +49.08%
Terns Pharmaceuticals
Dec 9, 2025
Maintains: Buy
Price Target: $35 → $56
Current: $40.40
Upside: +38.61%
Madrigal Pharmaceuticals
Nov 19, 2025
Maintains: Buy
Price Target: $580 → $640
Current: $582.34
Upside: +9.90%
Incyte
Oct 29, 2025
Reiterates: Hold
Price Target: $79 → $93
Current: $98.77
Upside: -5.84%
Protagonist Therapeutics
Oct 28, 2025
Maintains: Buy
Price Target: $76 → $88
Current: $87.34
Upside: +0.76%
Scholar Rock Holding
Oct 20, 2025
Maintains: Buy
Price Target: $54 → $44
Current: $44.05
Upside: -0.11%
Viatris
Oct 15, 2025
Initiates: Buy
Price Target: $15
Current: $12.45
Upside: +20.48%
MBX Biosciences
Oct 15, 2025
Initiates: Buy
Price Target: $50
Current: $31.54
Upside: +58.53%
Regeneron Pharmaceuticals
Aug 11, 2025
Maintains: Buy
Price Target: $940 → $812
Current: $771.87
Upside: +5.20%
May 5, 2025
Downgrades: Hold
Price Target: $21 → $11
Current: $11.86
Upside: -7.25%
Apr 29, 2025
Maintains: Buy
Price Target: $210 → $199
Current: $175.99
Upside: +13.07%
Apr 9, 2025
Maintains: Buy
Price Target: $43 → $25
Current: $20.36
Upside: +22.79%
Feb 3, 2025
Maintains: Buy
Price Target: $1,029 → $1,038
Current: $1,074.68
Upside: -3.41%
Feb 3, 2025
Maintains: Buy
Price Target: $211 → $217
Current: $228.49
Upside: -5.03%
Dec 18, 2024
Maintains: Buy
Price Target: $36 → $32
Current: $24.90
Upside: +28.51%
Nov 27, 2024
Maintains: Buy
Price Target: $33 → $50
Current: $24.82
Upside: +101.49%
Sep 27, 2024
Upgrades: Buy
Price Target: $54
Current: $1.24
Upside: +4,254.84%
Aug 13, 2024
Maintains: Buy
Price Target: $18 → $15
Current: $7.72
Upside: +94.30%
Jul 31, 2024
Initiates: Buy
Price Target: $36
Current: $18.97
Upside: +89.77%
May 29, 2024
Maintains: Buy
Price Target: $86 → $70
Current: $63.54
Upside: +10.17%